Microsoft
Selected early versions will be slated for real-world deployment.
The orchestrator includes customizable, multimodal AI agents to streamline oncology workflows like tumor boards and improve clinical decision-making.
The tech giant will offer access to the LLM for enterprise use as regulatory scrutiny mounts over the model’s data practices and medical diagnostic claims.